Kristine Curtiss
Corporate Officer/Principal chez PanOptica, Inc.
Profil
Kristine Curtiss is currently the Executive Director-Clinical Operations at PanOptica, Inc. She previously worked as the Director-Clinical Research at Oldtech, Inc., Director-Global Ophthalmology Programs at Oraya Therapeutics, Inc., Director-Ophthalmology Programs at OPKO Health, Inc., and Manager-Clinical Research at Hoffmann-La Roche, Inc. Curtiss received an undergraduate degree from the University of Delaware.
Postes actifs de Kristine Curtiss
| Sociétés | Poste | Début |
|---|---|---|
PanOptica, Inc.
 PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Corporate Officer/Principal | - |
Anciens postes connus de Kristine Curtiss
| Sociétés | Poste | Fin |
|---|---|---|
| OPKO HEALTH, INC. | Corporate Officer/Principal | - |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Directeur Technique/Scientifique/R&D | - |
Oraya Therapeutics, Inc.
 Oraya Therapeutics, Inc. Medical SpecialtiesHealth Technology Oraya Therapeutics, Inc. develops and commercializes a non-invasive therapy for wet age-related macular degeneration. The firm delivers a precise dose of radiation non-invasively to the macula using an automated positioning system and a localizing algorithm. The company was founded by Michael E. Gertner in 2006 and is headquartered in Newark, CA. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Directeur Technique/Scientifique/R&D | - |
Formation de Kristine Curtiss
| University of Delaware | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OPKO HEALTH, INC. | Health Services |
| Entreprise privées | 4 |
|---|---|
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Oraya Therapeutics, Inc.
Oraya Therapeutics, Inc. Medical SpecialtiesHealth Technology Oraya Therapeutics, Inc. develops and commercializes a non-invasive therapy for wet age-related macular degeneration. The firm delivers a precise dose of radiation non-invasively to the macula using an automated positioning system and a localizing algorithm. The company was founded by Michael E. Gertner in 2006 and is headquartered in Newark, CA. | Health Technology |
